Catherine Mott

Catherine Mott

Co-founder and Managing Partner of the BTVC Fund

Catherine Mott, Co-founder and Managing Partner of the BTVC Fund I, is also the founder of BlueTree Capital Group, BlueTree Allied Angels, and the BlueTree Venture Fund located in Pittsburgh, PA. Ms. Mott is the past Chairman of the Angel Capital Association (ACA) and the Angel Resource Institute and serves as a member of the ACA Public Policy Committee. Mott also is serving her fourth term as one of 21 individuals selected for the US SEC Advisory Committee on Small and Emerging Companies (renamed Small Business Capital Formation Advisory Committee). Catherine currently sits on the board of C360 Technologies, Cytoagents, Innovation Works (BFTP), Thiel College, NextAct Fund, Pittsburgh Tech Council and previously occupied board seats with RedPath Integrated Pathology, ShoeFitr, ApartmentJet, Safest Seats, Figure 8, Anglr, Imprint, Peptilogics

Catherine has been a contributor to the Smart Business Magazine (Pittsburgh edition), plus she has been quoted or featured in many professional industry publications as one of the few women who represent the industry of venture capital – The New York Times, Wall St Journal, Pittsburgh Post-Gazette, The Tribune Review, the Erie Times, PA KeyNotes, The Angel Journal, TEQ, Pop City, The Scientist. Prior to forming her own business, Catherine worked 17 years in corporate banking management where she served in senior management roles for investment sales/wealth management, commercial lending, business development, and retail expansion. Today, Ms. Mott uses these experiences and her education to bring together capital and prime investment opportunities. Catherine holds an MBA in Finance, a BS in Education, and a Masters’ Degree in Education.